PD-L1 inhibitor - Arbutus
PD-1 inhibitor - BMS
TIM-3 inhibitor - Partikula
https://www.onclive.com/view/novel-immunotherapy-combos-target-tim-3-and-pd-1-pd-l1-networks
 
Jan 7, 2022
 
Next